You're going to hear a lot more about "aspirin resistance"

May 2003

You're going to hear a lot more about "aspirin resistance."

Now that millions of people take low-dose aspirin to prevent cardiovascular disease, we're seeing that it doesn't always work.

About 10% of the population might be resistant to aspirin's antiplatelet effects. These patients might be up to 3 times more likely to have a heart attack or stroke.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote